circRNA Knockout Service: A Gateway to Understanding Circular RNA Functionality

0
13

Creative Biogene’s IntegrateRNA offers a groundbreaking circRNA knockout service, harnessing the transformative power of CRISPR/Cas9 technology. This service is tailored for researchers aiming to delve deeper into the world of circular RNAs (circRNAs) and their vital roles in various biological processes.

Understanding circRNA

Circular RNAs are unique biomolecules formed through the back-splicing of precursor mRNA, resulting in covalently closed structures. Their expression varies across species, tissues, and developmental stages, indicating their specific and critical functions in health and disease. Research highlights their involvement in significant diseases, such as cancer, diabetes, and neurodegenerative disorders. One of the most compelling reasons to study circRNAs lies in their multifunctional roles, acting as miRNA sponges, protein translation templates, and regulators of transcription.

Despite the recognition of their importance, a substantial number of circRNAs remain unexplored. To facilitate a comprehensive understanding of these molecules, loss-of-function experiments, like CRISPR/Cas9-mediated knockout, are essential.

Unique Strategies for circRNA Knockout

IntegrateRNA provides two innovative strategies for circRNA knockout:

  • Large Fragment Deletion: This approach utilizes two sgRNAs targeting the ends of the circRNA-forming exons, leading to the deletion of significant fragments of the circRNA. However, this method may impact the expression of linear RNAs, as they share overlapping sequences.

  • Targeting Intronic Complementary Sequences (ICS): By designing sgRNAs to target intronic sequences flanking the circRNA, this strategy minimizes circRNA generation while preserving the expression of the corresponding protein-coding genes. This targeted removal of intronic ICS can effectively decrease or even completely eliminate circRNA expression, offering a precise method for circRNA knockouts.

Advantages of Our Service

IntegrateRNA’s circRNA knockout service boasts several distinct advantages:

  • Extensive experience in utilizing the CRISPR/Cas9 system ensures reliability and efficacy.
  • Access to state-of-the-art equipment and cutting-edge technology optimizes the outcomes of each project.
  • Our commitment to providing high-quality services at competitive prices enables researchers to pursue their projects without breaking the bank.

We pride ourselves on customizing solutions to meet individual research requirements, enhancing the potential for groundbreaking discoveries in the circRNA field.

Conclusion

As circRNA research continues to evolve, the need for effective knockout strategies becomes paramount. IntegrateRNA stands ready to support researchers in their quest to unveil the complexities of circRNAs. For further information on our circRNA knockout service, please reach out to us. Let us assist you in your journey toward novel insights in gene regulation and disease mechanisms.

Search
Categories
Read More
Other
Smoke Detector Market Growth: Technology, Safety & Forecast
The smoke detector market is witnessing steady growth as safety regulations,...
By Pratik Mane 2026-06-24 09:27:28 0 1
Resources
Top IPTV Services 2026: Best IPTV Providers Reviewed
Discover the Top IPTV Services 2026. Compare features, pricing, streaming quality, device...
By Best IPTV 2026-06-08 05:31:25 0 297
Other
Best Ranked IPTV in 2026: Data-Driven Performance Rankings
In an industry flooded with bold claims and inflated promises, best ranked IPTV services earn...
By Best IPTV 2026-06-12 09:17:01 0 134
Other
How is the Automotive Ignition Coil Market Evolving Globally?
Automotive Ignition Coil Market Research Report The Automotive Ignition Coil Market is...
By Eknath Girhepunje 2026-05-20 11:11:53 0 324
Other
Targeted Cancer Drugs Market Forecast Report: Growth Drivers, Challenges, and Opportunities
"According to the latest report published by Data Bridge Market Research, the Targeted...
By Akanksha Didmuthe 2026-06-12 12:47:37 0 142